Hyperkalemia in the Hospital: Collaboration to Improve Transitions of Care.

Slides:

Advertisements

Similar presentations

Continuum of Care: Stroke Healthy Population At-Risk Population Stroke Event EMS Emergency Department HospitalRehabilitation.

Advertisements

The Importance of a Primary Care Physician Reliant Edge Solutions Health Homes.

 Sleep: Treatment and Cause for Low Back Pain Kevin Carneiro, D.O. University of North Carolina, Chapel Hill.

Prior Trials of RAAS Inhibitors

Diabetic Dyslipidemia in Practice

Emerging Concepts in Heart Failure

Current State of Hyperkalemia Management

NOACs for Cancer-Associated Thrombosis:

Introduction: Alarming Statistics Causes of Death in Prevalent Dialysis Patients,

Clinical Considerations in the Management of EGFR-Mutated Advanced NSCLC.

Starting Strong: Initial Evaluation of the Patient With HCV

PCP Perspectives Pathophysiologic Principles in the Management of Hyperkalemia.

New Therapies for Hyperkalemia Across the Continuum of Care

Emerging Data on ACS Management From ACC

The Nurse View.

At The Cutting Edge of Developments in the Management of Hyperkalemia

Updates Abound in Hyperkalemia Management

Addressing Neuropsychiatric Symptoms in Patients With Dementia

PCP Perspectives Clinical Considerations in Hyperkalemia

Cost Effectiveness and Optimal Outcomes in HF

A Call to Action on Cryptogenic Stroke

An Update on PCSK9 Inhibitors

Treating Vasodilatory Shock in the ICU

Treating HFrEF: Challenges Faced

Time to Take Gout Seriously

Expert Perspectives on Hyperkalemia for the Specialist

HCV Protease Inhibitors in Clinical Practice

Exploring Emerging Treatments for Hyperkalemia

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

PCSK9 Inhibitors and Cardiovascular Outcomes

Managing Depression is a Team Effort:

At The Cutting Edge of Developments in the Management of Hyperkalemia

Improving Appropriate Access to PCSK9 Inhibitors

Evaluating New Therapies in HF

The New Landscape of ABSSTI Treatment Opportunities to Improve Patient Care.

Multidisciplinary Management of Hyperkalemia:

Hyperkalemia in the Hospital

Improving 30-Day HF Readmission Rates With Biomarker-Guided Therapy

Shifting Currents in Hyperkalemia Management 2015 in Review

Shifting Currents in Hyperkalemia Management 2015 in Review

When to Start and What to Use

HCV Protease Inhibitors in Clinical Practice

Evaluating BTK Inhibitors in CLL

A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.

The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.

Current Controversies and Advances in Hepatorenal Syndrome

Maximizing Organ Protection in Patients With CKD and Comorbidities on RAAS Therapy.

Improving Effective Basal Insulin Use in Clinical Practice

Improving Adherence to Antiplatelet Therapy After an ACS Event

Assessing the Burden of Hyperkalemia

Breaking Down the Data in Hyperkalemia

Lipid Updates From Spring 2019

An Update on PCSK9 Inhibitors

Assessing the Burden of Hyperkalemia

Championing Evidence-Based Care in Patients With Acute Low Back Pain

Evaluating the Science of Cardiogenic Shock

Uptitration of Medications in HF: Start Low but Aim High and Stay High

In-Hospital Treatment for Heart Failure: New Approaches and a Renewed Sense of Hope?

Next-Generation Sequencing and ctDNA

Lipids, the Heart, and the Kidney

Clinical Comparisons.

My PAH Patient.

Key Data on Improving Outcomes in HF Patients

Care Team Collaboration for CAR T-Cell Therapy: Real-World Advice

RAASi Enabling in the Modern Era

Navigating the Journey

Shared-Decision Making in Dyslipidemia

Case-Based Look at Hyperkalemia Identification, Diagnosis, and Management.

Potassium Situations Resolved

Presentation transcript:

Hyperkalemia in the Hospital: Collaboration to Improve Transitions of Care

Program Goals

Hyperkalemia: Overview Episode or Long-Term Consequence?

Causes of Hyperkalemia

Hyperkalemia: The Continuum Clinical Presentation for In-Patient

Acute Treatment of Hyperkalemia: Effective, but Not a Long-Term Solution

The Emergency Department: Home for Acute Hyperkalemia

Hyperkalemia in the Hospital Setting

Hyperkalemia in the Critical Care Setting

Balancing RAAS Inhibitor Use and Potassium Level

Korean Study Evaluating Potassium Levels and Mortality in Dialysis Patients

Guidelines Recommendations Regarding RAAS Inhibitor Use Based on Serum Potassium Level

Methods to Lower Potassium Without Compromising Chronic Medical Therapy

Patiromer: Structure

AMETHYST-DN: Patiromer 52-Week Study

PEARL-HF: Patients With HF Receiving Standard Therapy and Spironolactone Treated With Patiromer

ZS-9: Structure

New Potassium Binders and Prevention of Hyperkalemia: Unanswered Questions and Clinical Implications

Comparison of SPS, Patiromer, and ZS-9

The Role of New Potassium-Binding Agents in Hypothetical Situations

Relationship Between Potassium Level and Patient Outcome

Managing Hyperkalemia Is a Team Effort

Transition of Care With Hyperkalemia: From Acute to Chronic Care

Key Takeaways

Abbreviations

Abbreviations (cont)